By 2026 #pancreatic cancer will be the fourth-biggest cancer killer (ref: @PancreaticCanUK). Time is ticking to discover better diagnostic methods and treatments. We are working hard to get our #ImmTAC candidate into clinical trials #PCAM
Most TCR therapies are designed to switch on the immune system’s response to cancer and infection. But we’re also developing TCR therapies that are meant to turn off the immune system when it attacks healthy cells. https://t.co/44M7WpYm06 #ImmTAAI
Our values are what make us who we are. We value the trust we have in each other, the diverse views we all bring, and the science that benefits patients. What do you value? #WorldValuesDay2022
Many patients in #oncology trials have exhausted available treatment options. A #clinicaltrial can offer hope, and an opportunity to learn about the potential safety and efficacy of an investigational therapy. https://t.co/h5lAe5zo8C
We’re absolutely thrilled to be nominated in three categories in this year’s #ScripAwards, including for Biotech Company of the Year and the Best New Drug Award for our world-first TCR treatment. Good luck to all innovation-seeking nominees! @PharmaScrip
Thank you #ESMO22 for organizing such a successful congress during which we were honored to share data updates for our approved and investigative bispecific TCR #cancer therapies.
Circulating tumour DNA (ctDNA) is a marker with growing importance in assessing how much and what type of cancer is in the body. More research is needed but it may help us to tailor treatment plans to each individual patient. #ESMO22#research#oncology
#ESMO22 is a place where scientific engagement happens, to deliver better care and treatment for patients. It’s also a place where people might look for their next opportunity. Come and talk to us at our booth or check out our vacancies online while you’re here #wearehiring
We will be at #ESMO22, where we will present data during the Immunotherapy proffered session, four posters, and meet with healthcare professionals. DM us if you would like to schedule a meeting or get more information.
Two days before #ESMO22 gets underway, we are holding our annual internal conference! Scientific engagement is the name of the game. #ImmPACT#YourImmunocore
T cells come packed with lytic granules. The purpose of an #ImmTAC is to mark a cancer target, telling T cells to release their granules and kill the cancer. This is called ‘lysing’. #YourImmunocore#immunooncology
I love this story because it reminds me that one person can make a difference.
In 1979, Jadav Payeng began planting a tree every day for 37 years — results are stunning
Dr. Jedd Wolchok, an esteemed physician-scientist who pioneered immunotherapy for the treatment of melanoma, is the new director of the @WCM_MeyerCancer. Join us in welcoming him to this leadership role that unites cancer research across the institution. https://t.co/R46Q9vFzgQ